GRASSI, GABRIELE
 Distribuzione geografica
Continente #
EU - Europa 35.289
NA - Nord America 21.406
AS - Asia 9.210
SA - Sud America 1.116
AF - Africa 264
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 33
AN - Antartide 1
Totale 67.382
Nazione #
IT - Italia 23.637
US - Stati Uniti d'America 21.063
SG - Singapore 3.365
CN - Cina 2.848
PL - Polonia 2.197
DE - Germania 1.741
SE - Svezia 1.673
HK - Hong Kong 1.086
UA - Ucraina 1.060
BR - Brasile 878
FR - Francia 857
GB - Regno Unito 811
RU - Federazione Russa 807
FI - Finlandia 581
NL - Olanda 491
TR - Turchia 474
VN - Vietnam 374
KR - Corea 339
IE - Irlanda 284
BG - Bulgaria 280
CH - Svizzera 244
CA - Canada 212
IN - India 186
BE - Belgio 113
MA - Marocco 109
ES - Italia 89
JP - Giappone 87
MX - Messico 81
BD - Bangladesh 65
IR - Iran 64
AR - Argentina 62
AT - Austria 61
AU - Australia 55
RO - Romania 53
SN - Senegal 41
ZA - Sudafrica 41
IQ - Iraq 39
EC - Ecuador 38
CZ - Repubblica Ceca 36
AL - Albania 34
EU - Europa 31
ID - Indonesia 29
PK - Pakistan 28
GR - Grecia 27
LU - Lussemburgo 27
PY - Paraguay 27
SA - Arabia Saudita 27
CO - Colombia 26
DK - Danimarca 26
CL - Cile 25
VE - Venezuela 25
IL - Israele 24
PT - Portogallo 24
SI - Slovenia 22
TW - Taiwan 22
HR - Croazia 20
EG - Egitto 18
MY - Malesia 18
LT - Lituania 17
PE - Perù 17
AE - Emirati Arabi Uniti 15
RS - Serbia 15
TH - Thailandia 15
UZ - Uzbekistan 14
KE - Kenya 13
JO - Giordania 12
NO - Norvegia 11
DZ - Algeria 10
JM - Giamaica 10
EE - Estonia 9
PA - Panama 9
UY - Uruguay 9
AZ - Azerbaigian 8
TN - Tunisia 8
GE - Georgia 7
HU - Ungheria 7
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
KZ - Kazakistan 6
MD - Moldavia 6
MO - Macao, regione amministrativa speciale della Cina 6
NP - Nepal 6
NZ - Nuova Zelanda 6
SM - San Marino 6
BO - Bolivia 5
BY - Bielorussia 5
GD - Grenada 5
LV - Lettonia 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
LB - Libano 4
MU - Mauritius 4
NG - Nigeria 4
NI - Nicaragua 4
QA - Qatar 4
BH - Bahrain 3
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
PH - Filippine 3
Totale 67.321
Città #
Ashburn 2.126
Woodbridge 1.947
Warsaw 1.884
Ann Arbor 1.797
Fairfield 1.769
Singapore 1.716
Chandler 1.607
Houston 1.368
Rome 1.211
Trieste 1.199
Milan 1.193
Hong Kong 1.050
Jacksonville 1.009
Wilmington 873
Hefei 796
Beijing 726
Seattle 699
Cambridge 596
Princeton 490
Boardman 479
Izmir 390
Naples 348
San Jose 337
Seoul 315
Santa Clara 303
Dearborn 302
Columbus 295
Los Angeles 288
Sofia 274
Dublin 273
Dallas 260
Florence 255
Moscow 248
Bologna 230
Zgierz 229
Turin 222
The Dalles 202
Padova 196
Helsinki 178
Palermo 175
London 169
Napoli 157
Munich 146
Buffalo 144
Düsseldorf 142
Ho Chi Minh City 130
Bari 123
Torino 118
Frankfurt am Main 113
Genoa 113
Brescia 110
San Diego 105
Catania 100
New York 97
Brussels 91
Verona 90
São Paulo 89
Venezia 89
Udine 88
Redwood City 86
Casablanca 85
Chicago 84
Cagliari 83
Hanoi 75
Grafing 74
North Bergen 74
Venice 70
Bern 68
Perugia 67
Redmond 67
Shanghai 67
Turku 64
Bergamo 63
Bremen 58
Tokyo 58
Guangzhou 57
Mestre 57
Treviso 56
Toronto 55
Montreal 52
Phoenix 51
Como 50
Monza 50
Washington 50
Genova 48
Mountain View 48
Nanjing 48
Pescara 48
Salerno 47
Caserta 46
Des Moines 46
Messina 45
Falls Church 43
Lauterbourg 43
Kunming 42
Dakar 41
Duino-Aurisina 41
Brooklyn 40
Dong Ket 40
Orem 40
Totale 34.396
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.666
VALUTAZIONE DEL TOUCH-IMPRINT CITOLOGICO NEL TRATTAMENTO DEL CANCRO DELLA MAMMELLA 1.302
Polysaccharides for the delivery of antitumor drugs 448
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 445
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 441
Potential applications of nanocellulose-containing materials in the biomedical field 425
A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture. 410
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 372
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 358
Use of low field NMR for the characterization of gels and biological tissues 351
Antibacterial drug release from a biphasic gel system: Mathematical modelling 346
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma 333
Theoretical importance of pvp-alginate hydrogels structure on drug release kinetics 324
Physical characterization of alginate–Pluronic F127 gel for endoluminal NABDs delivery 303
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases 297
Strategies for delivery of siRNAs to ovarian cancer cells 294
Combined Used of Rheology and LF-NMR for the Characterization of PVP-Alginates Gels Containing Liposomes 292
Therapeutic potential and delivery strategies for nucleic acid-based drugs 285
Breastfeeding is an additional protective factor for breast cancer among women living in the metropolitan area of Trieste. 285
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 280
Parità e Allattamento quali fattori protettivi di carcinoma mammario nelle donne triestine 277
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 276
In vitro metabolic zonation through oxygen gradient on a chip 275
Engineering approaches in siRNA delivery 273
Studio matematico di un sistema antiossidante per uso alimentare a base di acido ascorbico 270
Characterization of PLLA scaffolds for biomedical applications 268
The role of the transcription factor E2F1 in hepatocellular carcinoma 265
Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot 263
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 258
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 255
Ottimizzazione di hydrogel alginato-pluronico per il rilascio di farmaci basati sul DNA 255
Mathematical modeling of drug release from natural polysaccharides based matrices 254
A physiologically-oriented mathematical model for the description of in vivo drug release and absorption 252
Synthesis and characterization of UV photocrosslinkable hydrogels with poly(N-vinyl-2-pyrrolidone): Determination of the network mesh size distribution 250
2D DYNAMICAL SIMULATION OF A VIBRATIONAL MILL 249
Exploring the Shape Influence on Melting Temperature, Enthalpy, and Solubility of Organic Drug Nanocrystals by a Thermodynamic Model 248
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 246
Growth Rate of Small Abdominal Aortic Aneurysms and Genetic Polymorphisms of Matrix MetalloProteases-1, -3, and -9 246
Mathematical modeling of L-(+)-ascorbic acid delivery from pectin films (packaging) to agar hydrogels (food) 246
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 244
Chemical engineering in the “BIO” world 240
Thermo-responsive hydrogels from cellulose-based polyelectrolytes and catanionic vesicles for biomedical application 240
Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment 233
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 233
Use of Low field NMR for the characterisation of gels and biological tissues 233
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 230
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 229
Membranes in Drug Delivery 228
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 227
Mass balance: an old concept for the new challenges proposed by personalized medicine 225
Drug delivery from polymeric matrices 224
Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase finctional polymorphisms. 220
Translation Elongation 220
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 220
Designing of polymeric gels mimicking the normal and fibrotic liver tissues: Effect of viscoelasticity on cells adhesion and survival 220
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 219
Modulating carbohydrate-based hydrogels as viscoelastic lubricant substitute for articular cartilages 217
Rilascio di farmaci da matrici viscoelastiche: punto di incontro tra modello e dati sperimentali 216
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 216
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 212
An update of aberrant methylation detection on circulating cell-free DNA as a tool to improve prostate cancer diagnosis and prognosis 212
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 210
Novel design of drug delivery in stented arteries: a numerical comparative study 209
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 209
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 206
A rapid procedure for the quantitation of low abundance RNAs by competitive reverse transcription-polymerase chain reaction 205
METODO E CONNESSO APPARATO PER ANALISI DI UN CAMPIONE DI ESPETTORATO 204
null 203
Monitoring sputum properties in cystic fibrosis patients by means of Low-Field NMR before after kaftrio treatment 199
Mathematical modelling of antibacterial release from a biphasic gel system 199
A rapid and specific method to simultaneously quantify eukaryoticelongation factor 1A1 and A2 protein levels in cancer cells 197
Can rheology be useful in the cystic fibrosis frame 196
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 195
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 194
Hydrogel basati sul PVP per il drug delivery da microcontainer 193
"Charactherization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices" 191
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 188
Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66ShcA in pacemaker-implanted patients. 188
Drug mechanochemical activation 187
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 187
Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects 186
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 185
Correlazione vitro-vivo e modelli matematici 185
null 184
Comparison between recombinant baculo and adenoviral-vectors as transfer system in cardiovascular cells 181
Caratterizzazione reologico/NMR di gel composti da alginato-pluronico per il rilascio di farmaci basati sul DNA 181
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 180
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing 178
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 177
Effects of hypoxia and bed rest on markers of cardiometabolic risk: Compensatory changes in circulating trail and glutathione redox capacity 177
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 177
Rheological and mechanical properties of pluronic-alginate gels for drug-eluting stent coating 175
Functional reconstitution of oxidase activity in X-Linked chronic granulomatous disease by retrovirus-mediated gene transfer 173
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 173
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 173
Swelling of viscoelastic matrices by viscoelastic fluids 173
Epigenetic and miRNAs dysregulation in prostate cancer: the role of nutraceuticals. 173
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 173
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 172
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. 169
Totale 46.446
Categoria #
all - tutte 155.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.515 0 0 0 0 0 0 383 431 393 558 280 470
2021/20224.621 244 297 233 497 197 379 266 252 465 420 447 924
2022/20238.700 750 880 713 912 740 1.091 366 740 830 380 721 577
2023/20246.324 639 547 504 457 588 511 736 796 133 457 518 438
2024/20258.260 364 473 660 710 871 722 533 514 1.034 927 664 788
2025/20268.670 1.767 957 1.217 1.512 1.294 1.484 439 0 0 0 0 0
Totale 68.534